Frankfurter Buchmesse is the world’s most important marketplace for print and digital content. It’s also an extraordinary social and cultural event. Every October, publishing experts, writers, creative professionals and fans come from all over the world to network, hold discussions, negotiate, take decisions, be amazed and celebrate.
HighWire will once more be exhibiting at the show. You can find us at Stand L45 in Hall 4.2.
On Wednesday 16th, the focus on the Academic & Business Information Stage in Hall 4.2 will be on innovations in academic publishing.
We’ll be chairing a panel at 5pm where we will discuss the recent launch of medRxiv and explore how the publishing process can be made more iterative in the future.
Science as conversation: the evolving role of preprint servers
- 5pm, Wednesday 16th, 2019
- Academic & Information Stage, Hall 4.2
- Speakers: Dr. John Inglis (Founder of medRxiv and bioRxiv, Cold Spring Harbor Press), Darla Henderson (Publisher, Global Journals Development, ACS), and Daniel Himmelstein (Postdoctoral Fellow, University of Pennsylvania and co-founder of Manubot). Chaired by Jim Longo, VP of Product & Development, HighWire.
Science is a continuous process: an ongoing conversation between researchers as they test, retest, rebut and refute each other’s work. However, this fluidity is not supported by the traditional scholarly publishing workflow, a long-tail process where researchers can wait months or sometimes years for the publication of a journal. When that publication does come, journals are often less an iterative part of the conversation, and more of a full-stop: an monolithic and largely immutable piece of content.
Perhaps this explains the exponential growth in the use of preprint server, with more manuscripts posted to the 5 year old bioRxiv server in 2018 than in the 4 years previous. With the popularity of preprints bolstered last year by policy mandating preprints for all research supported by the Chan Zuckerberg Initiative, this year has seen the launch of medRxiv– with rigorous screening processes implemented to allay the risks of unvetted medical research.
In this session, we will discuss the evolving role and importance of the preprint archive, its risks and how to mitigate against them, as well as touching upon other ways we might be able to make the publishing process more iterative and collaborative in the future.